In-Vitro Lung Model Global Market Report 2024 - By Trends, Size, Share, Demand And Growth, Outlook By 2033

"The new report published by The Business Research Company, titled ""In-Vitro Lung Model Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the in vitro lung model market size has grown exponentially in recent years. It will grow from $0.37 billion in 2023 to $0.44 billion in 2024 at a compound annual growth rate (CAGR) of 21%. The vitro lung model market size is expected to see exponential growth in the next few years. It will grow to $0.96 billion in 2028 at a compound annual growth rate (CAGR) of 21.1%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

Increasing Clinical Studies Propel Growth Of In Vitro Lung Model Market
The increase in clinical studies is expected to propel the growth of the in vitro lung model market going forward. Clinical trials refer to research studies that test how well new medical approaches work in people. The increase in clinical studies is driven by the growing need for advanced medical treatments, rising healthcare demands, and the pursuit of innovative solutions to complex health issues. In vitro lung models help in clinical trials by providing a controlled environment to study the effects of substances on lung tissue, aiding in drug testing, toxicity assessment, disease modeling, and understanding disease mechanisms. For instance, in January 2024, according to ClinicalTrials.gov, a US-based clinical trial registry, by the end of 2023, 477,230 clinical trials registered globally on ClinicalTrials.gov, an increase compared to 437,508 registered clinical trials in 2022. Therefore, the increase in clinical studies drives the in vitro lung model market.

Advancements in 3D Respiratory Tissue Models
Major companies operating in the invitro lung model market are developing 3D respiratory tissue models to enhance their models' physiological relevance and complexity. 3D respiratory tissue models are created by culturing selected respiratory cells in a specialized environment, allowing them to assemble into a three-dimensional structure miming the respiratory system's function and morphology, providing a more physiologically relevant platform for research and drug testing. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, introduced EpiNasal, an innovative 3D respiratory tissue model made from primary human nasal epithelial cells. It replicates the three-dimensional structure and functionality of nasal epithelium, including mucus-producing goblet cells, functional tight junctions, and cilia that beat. The introduction of EpiNasal expands MatTek's portfolio of 3D respiratory tissue models. This model offers a comprehensive system for studying the effects of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.

The in-vitro lung model market covered in this report is segmented -
1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model
2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15835&type=discount

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper* Laboratory Inc. , STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

Contents of the report:
1. Executive Summary
2. In-Vitro Lung Model Market Report Structure
3. In-Vitro Lung Model Market Trends And Strategies
4. In-Vitro Lung Model Market - Macro Economic Scenario
5. In-Vitro Lung Model Market Size And Growth
…..
27. In-Vitro Lung Model Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.